Department of Nuclear Medicine, University Medical Centre Ljubljana, Zaloška cesta 7, 1000 Ljubljana, Slovenia.
Faculty of Mathematics and Physics, University of Ljubljana, Jadranska ulica 19, 1000 Ljubljana, Slovenia.
Phys Med. 2022 Jun;98:131-138. doi: 10.1016/j.ejmp.2022.04.016. Epub 2022 May 7.
Differentiation between neurodegenerative parkinsonisms, whose early clinical presentation is similar, may be improved with metabolic brain imaging. In this study we applied a specific network analysis to 2-[F]FDG PET brain scans to identify the characteristic metabolic patterns for multiple system atrophy (MSA) and progressive supranuclear palsy (PSP) in a new European cohort. We also developed a new tool to recognize and estimate patients' metabolic brain heterogeneity.
20 MSA-P patients, 20 PSP patients and 20 healthy controls (HC) underwent 2-[F]FDG PET brain imaging. The scaled subprofile model/principal component analysis was applied to identify MSA/PSP-related patterns; MSARP and PSPRP. Additional, 56 MSA, 45 PSP, 116 PD and 61 HC subjects were analyzed for validation. We innovatively applied heat-map analysis to extract and graphically display the pattern's regional sub-scores in individual subjects.
MSARP was characterized by hypometabolism in cerebellum and putamen, and PSPRP by hypometabolism in medial prefrontal cortices, nucleus caudatus, frontal cortices and mesencephalon. Patterns' expression discriminated between MSA/PSP patients and HCs as well as between different parkinsonian cohorts (p < 0.001). Both patterns were sensitive and specific (AUC for MSARP/PSPRP: 0.96/0.99). Heat-map analysis showed differences within MSA/PSP subjects and HCs consistent with clinical presentation.
Replication and validation of MSARP and PSPRP confirms robustness of these metabolic biomarkers and supports its application in clinical and research practice. Heat-map analysis gives us an insight into the contribution of various pattern's regions to patterns' expression in individual subjects, which improves our insight into the heterogeneity of studied syndromes.
具有相似早期临床表现的神经退行性帕金森病之间的鉴别可以通过代谢性脑成像得到改善。在这项研究中,我们应用了一种特定的网络分析方法对 2-[F]FDG PET 脑扫描进行分析,以确定多系统萎缩(MSA)和进行性核上性麻痹(PSP)在新的欧洲队列中的特征代谢模式。我们还开发了一种新的工具来识别和估计患者的代谢性脑异质性。
20 名 MSA-P 患者、20 名 PSP 患者和 20 名健康对照者(HC)接受了 2-[F]FDG PET 脑成像。采用标度子模型/主成分分析(SSM/PCA)来识别 MSA/PSP 相关模式;MSARP 和 PSPRP。此外,对 56 名 MSA、45 名 PSP、116 名 PD 和 61 名 HC 患者进行了分析。我们创新性地应用热图分析来提取和图形化显示个体受试者中模式的区域子评分。
MSARP 的特征是小脑和壳核代谢低下,PSPRP 的特征是内侧前额叶皮质、尾状核、额叶皮质和中脑代谢低下。模式的表达可以区分 MSA/PSP 患者和 HC 以及不同的帕金森病患者队列(p<0.001)。两种模式均具有敏感性和特异性(MSARP/PSPRP 的 AUC:0.96/0.99)。热图分析显示 MSA/PSP 患者和 HC 之间存在差异,与临床表现一致。
MSARP 和 PSPRP 的复制和验证证实了这些代谢生物标志物的稳健性,并支持其在临床和研究实践中的应用。热图分析使我们能够深入了解各个模式区域对个体受试者中模式表达的贡献,从而提高我们对所研究综合征异质性的认识。